Breakthrough Therapy Designation for New Drugs
JAMA
.
2018 Nov 20;320(19):2042.
doi: 10.1001/jama.2018.15938.
Author
Edward J Benz Jr
1
Affiliation
1
Dana-Farber Cancer Institute, Boston, Massachusetts.
PMID:
30458486
DOI:
10.1001/jama.2018.15938
No abstract available
Publication types
Letter
Comment
MeSH terms
Drug Approval*
Drug Evaluation
United States Food and Drug Administration*